These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 37949482)
1. Cerebral small vessel disease modifies outcomes after minimally invasive surgery for intracerebral haemorrhage. Li Y; Cho SM; Avadhani R; Ali H; Hao Y; Murthy SB; Goldstein JN; Xia F; Hu X; Ullman NL; Awad I; Hanley D; Ziai WC Stroke Vasc Neurol; 2024 Aug; 9(4):446-456. PubMed ID: 37949482 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Hanley DF; Thompson RE; Muschelli J; Rosenblum M; McBee N; Lane K; Bistran-Hall AJ; Mayo SW; Keyl P; Gandhi D; Morgan TC; Ullman N; Mould WA; Carhuapoma JR; Kase C; Ziai W; Thompson CB; Yenokyan G; Huang E; Broaddus WC; Graham RS; Aldrich EF; Dodd R; Wijman C; Caron JL; Huang J; Camarata P; Mendelow AD; Gregson B; Janis S; Vespa P; Martin N; Awad I; Zuccarello M; Lancet Neurol; 2016 Nov; 15(12):1228-1237. PubMed ID: 27751554 [TBL] [Abstract][Full Text] [Related]
3. Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trial. Sun P; Badihian S; Avadhani R; Walborn N; Yarava A; Alimoradi D; Awad I; Hanley D; Murthy S; Ziai W J Neurol Neurosurg Psychiatry; 2024 Sep; 95(10):892-898. PubMed ID: 38670789 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Hanley DF; Thompson RE; Rosenblum M; Yenokyan G; Lane K; McBee N; Mayo SW; Bistran-Hall AJ; Gandhi D; Mould WA; Ullman N; Ali H; Carhuapoma JR; Kase CS; Lees KR; Dawson J; Wilson A; Betz JF; Sugar EA; Hao Y; Avadhani R; Caron JL; Harrigan MR; Carlson AP; Bulters D; LeDoux D; Huang J; Cobb C; Gupta G; Kitagawa R; Chicoine MR; Patel H; Dodd R; Camarata PJ; Wolfe S; Stadnik A; Money PL; Mitchell P; Sarabia R; Harnof S; Barzo P; Unterberg A; Teitelbaum JS; Wang W; Anderson CS; Mendelow AD; Gregson B; Janis S; Vespa P; Ziai W; Zuccarello M; Awad IA; Lancet; 2019 Mar; 393(10175):1021-1032. PubMed ID: 30739747 [TBL] [Abstract][Full Text] [Related]
5. Cerebral small vessel disease burden and functional and radiographic outcomes in intracerebral hemorrhage. Lioutas VA; Wu B; Norton C; Helenius J; Modak J; Selim M J Neurol; 2018 Dec; 265(12):2803-2814. PubMed ID: 30242743 [TBL] [Abstract][Full Text] [Related]
6. Association between remote diffusion-weighted imaging lesions and cerebral small vessel disease in primary intracerebral hemorrhage. Xu XH; Ye XH; Li JW; Cai JS; Gao T; Zhang WJ; Zhao GH; Tong LS; Gao F Eur J Neurol; 2019 Jul; 26(7):961-968. PubMed ID: 30742740 [TBL] [Abstract][Full Text] [Related]
7. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial. Al-Shahi Salman R; Minks DP; Mitra D; Rodrigues MA; Bhatnagar P; du Plessis JC; Joshi Y; Dennis MS; Murray GD; Newby DE; Sandercock PAG; Sprigg N; Stephen J; Sudlow CLM; Werring DJ; Whiteley WN; Wardlaw JM; White PM; Lancet Neurol; 2019 Jul; 18(7):643-652. PubMed ID: 31129065 [TBL] [Abstract][Full Text] [Related]
8. End-of-Treatment Intracerebral and Ventricular Hemorrhage Volume Predicts Outcome: A Secondary Analysis of MISTIE III. de Havenon A; Joyce E; Yaghi S; Ansari S; Delic A; Taussky P; Alexander M; Tirschwell D; Grandhi R Stroke; 2020 Feb; 51(2):652-654. PubMed ID: 31842688 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic Evaluation of Diffusion Weighted Hyperintense Lesions After Large Spontaneous Intracerebral Hemorrhage: A Subgroup Analysis of MISTIE III. Rivera-Lara L; Cho SM; Li Y; Ali H; McBee N; Awad IA; Avadhani R; Hanley DF; Gandhi D; Walborn N; Murthy SB; Ziai WC Neurocrit Care; 2024 Jun; 40(3):1140-1150. PubMed ID: 38040993 [TBL] [Abstract][Full Text] [Related]
10. Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure. Awad IA; Polster SP; Carrión-Penagos J; Thompson RE; Cao Y; Stadnik A; Money PL; Fam MD; Koskimäki J; Girard R; Lane K; McBee N; Ziai W; Hao Y; Dodd R; Carlson AP; Camarata PJ; Caron JL; Harrigan MR; Gregson BA; Mendelow AD; Zuccarello M; Hanley DF; Neurosurgery; 2019 Jun; 84(6):1157-1168. PubMed ID: 30891610 [TBL] [Abstract][Full Text] [Related]
11. Higher cerebral small vessel disease burden is associated with smaller hematoma volume in mixed-location intracerebral hemorrhage. Xu M; Cheng Y; Zhang S; Zhang S; Song Q; Zheng L; Liu M; Liu M Microcirculation; 2021 Aug; 28(6):e12705. PubMed ID: 33977609 [TBL] [Abstract][Full Text] [Related]
12. Safety and technical efficacy of early minimally invasive endoscopy-guided surgery for intracerebral haemorrhage: the Dutch Intracerebral haemorrhage Surgery Trial pilot study. Sondag L; Schreuder FHBM; Pegge SAH; Coutinho JM; Dippel DWJ; Janssen PM; Vandertop WP; Boogaarts HD; Dammers R; Klijn CJM; Acta Neurochir (Wien); 2023 Jun; 165(6):1585-1596. PubMed ID: 37103585 [TBL] [Abstract][Full Text] [Related]
13. Minimally Invasive Surgery With Thrombolysis for Intracerebral Hemorrhage Evacuation: Bayesian Reanalysis of a Randomized Controlled Trial. Bako AT; Potter T; Pan AP; Tannous J; Britz G; Ziai WC; Awad I; Hanley D; Vahidy FS Neurology; 2023 Oct; 101(16):e1614-e1622. PubMed ID: 37684058 [TBL] [Abstract][Full Text] [Related]
14. Total small vessel disease score and functional outcomes following acute intracerebral hemorrhage. Kimura Y; Miwa K; Takasugi J; Oyama N; Todo K; Sakaguchi M; Mochizuki H; Sasaki T J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):105001. PubMed ID: 32689644 [TBL] [Abstract][Full Text] [Related]
15. Kidney Dysfunction is Associated with a High Burden of Cerebral Small Vessel Disease in Primary Intracerebral Hemorrhage. Xu M; Zhang S; Liu J; Luo H; Wu S; Cheng Y; Liu M Curr Neurovasc Res; 2018; 15(1):39-46. PubMed ID: 29577861 [TBL] [Abstract][Full Text] [Related]
16. Cerebral Small Vessel Disease and Depression Among Intracerebral Hemorrhage Survivors. Castello JP; Pasi M; Kubiszewski P; Abramson JR; Charidimou A; Kourkoulis C; DiPucchio Z; Schwab K; Anderson CD; Gurol ME; Greenberg SM; Rosand J; Viswanathan A; Biffi A Stroke; 2022 Feb; 53(2):523-531. PubMed ID: 34587793 [TBL] [Abstract][Full Text] [Related]
17. Cerebral small vessel disease and prognosis in intracerebral haemorrhage: A systematic review and meta-analysis of cohort studies. Cheng Z; Zhang W; Zhan Z; Xia L; Han Z Eur J Neurol; 2022 Aug; 29(8):2511-2525. PubMed ID: 35435301 [TBL] [Abstract][Full Text] [Related]
18. Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial. Fam MD; Hanley D; Stadnik A; Zeineddine HA; Girard R; Jesselson M; Cao Y; Money L; McBee N; Bistran-Hall AJ; Mould WA; Lane K; Camarata PJ; Zuccarello M; Awad IA Neurosurgery; 2017 Nov; 81(5):860-866. PubMed ID: 28402516 [TBL] [Abstract][Full Text] [Related]
19. Hypertension control after intracerebral hemorrhage among varying small vessel disease etiologies. Das AS; Mallick A; Mora SA; Keins S; Abramson JR; Castello JP; Pasi M; Kourkoulis CE; Rodriguez-Torres A; Warren AD; Gökçal E; Viswanathan A; Greenberg SM; Anderson CD; Rosand J; Biffi A; Gurol ME Neurol Sci; 2024 Oct; 45(10):4913-4921. PubMed ID: 38772978 [TBL] [Abstract][Full Text] [Related]
20. Minimally invasive surgery for intracerebral haemorrhage. Barnes B; Hanley DF; Carhuapoma JR Curr Opin Crit Care; 2014 Apr; 20(2):148-52. PubMed ID: 24553341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]